Koyfin Home > Directory > Health Care > Abeona Therapeutics > Gross Margin

Abeona Therapeutics Gross Margin Chart (ABEO)

Abeona Therapeutics annual/quarterly Gross Margin from 2010 to 2018. Gross margin is a company's total sales revenue minus its cost of goods sold (COGS), divided by total sales revenue, expressed as a percentage. The higher the percentage, the more the company retains on each dollar of sales, to service its other costs and debt obligations.
  • Abeona Therapeutics Gross Margin for the quarter ending December 12, 2018 was $-1,865m a 22.93% decrease of -428m year over year
  • Abeona Therapeutics Gross Margin for the last 12 months ending September 09, 2019 was $-9,948m a 88.03% decrease of -8,757m year over year
  • Abeona Therapeutics Annual Gross Margin for 2018 was $-1,191m a -62.06% increase of 739m from 2017
  • Abeona Therapeutics Annual Gross Margin for 2017 was $-1,930m a 43.07% decrease of -831m from 2016
  • Abeona Therapeutics Annual Gross Margin for 2016 was $-1,099m a 109.10% decrease of -1,199m from 2015
Other Margins & Efficiency Metrics:
  • Abeona Therapeutics EBITDA Margin for the quarter ending December 12, 2014 was $-196m a 79.05% decrease of -155m year over year
  • Abeona Therapeutics Return on Capital % for the quarter ending September 09, 2018 was -27.18 a 38.09% decrease of -10.35 year over year
  • Abeona Therapeutics Return on Equity % for the quarter ending September 09, 2018 was -42.21 a 38.40% decrease of -16.21 year over year
View Chart On Koyfin

Quarterly ABEO Gross Margin Data

12/2018$-1,865m
09/2018$-669m
06/2018$-2,768m
03/2018$-1,437m
12/2017$-2,554m
09/2017$-1,396m
06/2017$-2,576m
03/2017$-1,082m
12/2016$100m
09/2016$100m

Annual ABEO Gross Margin Data

2018$-1,191m
2017$-1,930m
2016$-1,099m
2015$100m
2014$100m
2013$94m
2012$94m
2011$92m
2010$-625m